Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Xeljanz
Xeljanz
Pfizer + relationship expert = RA connection?
BioPharma Dive
Fri, 02/17/17 - 09:55 am
Pfizer
rheumatoid arthritis
Xeljanz
Pfizer says rheumatoid arthritis drug is comparable to Humira as combination treatment but not alone
Marketwatch
Thu, 02/16/17 - 03:13 pm
Pfizer
Xeljanz
AbbVie
Humira
rheumatoid arthritis
Pfizer's 3 Fastest-Growing Drugs
Motley Fool
Wed, 02/1/17 - 09:58 am
Pfizer
Ibrance
Eliquis
Xeljanz
Pfizer Has Strong Track Record since 2010
Market Realist
Fri, 12/16/16 - 11:29 am
Pfizer
drug approvals
Ibrance
Prevnar 13
Inlyta
Xalkori
Xeljanz
Pfizer’s Xeljanz Expected to See Strong Growth Trends in 2016
Market Realist
Thu, 11/17/16 - 04:52 pm
Pfizer
Xeljanz
rheumatoid arthritis
Pfizer anchors inflammation hopes in Xeljanz
BioPharma Dive
Wed, 10/19/16 - 06:47 pm
Pfizer
Xeljanz
inflammation
Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016
Yahoo
Sat, 10/15/16 - 12:18 pm
Pfizer
Xeljanz
ulcerative colitis
Will Sales of Xeljanz Offset Falling Sales of Enbrel?
Market Realist
Tue, 09/6/16 - 09:47 am
Pfizer
Xeljanz
Enbrel
rheumatoid arthritis
JAK inhibitors
Recent Corporate and Pipeline Developments for Pfizer
Market Realist
Mon, 08/15/16 - 11:07 am
Pfizer
M&A
Bamboo Therapeutics
Anacor
Western Oncolytics
avelumab
Xeljanz
bococizumab
ertugliflozin
utomilumab
Pfizer Inc: Can New Drugs Growth Eliminate the Need for a Split-up?
Bidness, ETC
Thu, 08/4/16 - 09:40 am
Pfizer
Ibrance
Xeljanz
Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ® (Tofacitinib Citrate) in Ulcerative Colitis
Yahoo
Fri, 07/29/16 - 11:30 am
Pfizer
Xeljanz
clinical trials
ulcerative colitis
With competition lurking, Eli Lilly's baricitinib must show unparalled efficacy
Medical Marketing and Media
Wed, 05/11/16 - 10:52 am
Eli Lilly
baricitinib
JAK inhibitors
Pfizer
Xeljanz
Enbrel
AbbVie
Humira
JNJ
Remicade
Gilead joins Pfizer and Eli Lilly in JAK Race
Bidness, ETC
Sun, 12/27/15 - 10:24 am
Gilead Sciences
JAK inhibitors
Pfizer
Eli Lilly
filgotinib
Galapagos
Xeljanz
baricitinib
Pfizer gives up on a pair of Xeljanz indications--and it may dump psoriasis, too
Fierce Pharma
Thu, 10/29/15 - 09:05 am
Pfizer
Xeljanz
psoriasis
ankylosing spondylitis
Chron's Disease
The FDA Turns Pfizer Away, but Few Are Surprised
Motley Fool
Fri, 10/16/15 - 07:51 pm
FDA
Pfizer
Xeljanz
FDA declines to expand approval of Pfizer arthritis drug
Yahoo/Reuters
Thu, 10/15/15 - 08:45 am
FDA
Pfizer
Xeljanz
chronic plaque psoriasis
Psoriasis data wars heat up at AAD with Novartis, Boehringer studies
Fierce Pharma Marketing
Thu, 03/26/15 - 07:38 am
Novartis
psoriasis
Boehringer Ingelheim
Pfizer
Xeljanz
Cosentyx
JNJ
Stelara
BI-655066
Amgen
AstraZeneca
Merck
Eli Lilly
Pfizer Arthritis drug leads to full head of hair
CNBC
Mon, 06/23/14 - 09:40 am
Pfizer
alopecia
rheumatoid arthritis
Xeljanz
Pfizer XELJANZ Phase 3 findings support safety, efficacy
Yahoo/Fly on the Wall
Wed, 06/18/14 - 05:39 pm
Pfizer
Xeljanz
rheumatoid arthritis
Psoriasis study does little to help Pfizer with Xeljanz
Fierce Pharma
Fri, 10/11/13 - 09:37 am
Pfizer
psoriasis
Xeljanz
Pages
« first
‹ previous
1
2
3
4
next ›
last »